Aprio Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
3,328
-31
-0.9% -$10.6K 0.06% 203
2026
Q1
$1.18M Buy
3,359
+373
+12% +$133K 0.06% 176
2025
Q4
$977K Buy
2,986
+1,329
+80% +$422K 0.06% 201
2025
Q3
$468K Sell
1,657
-25
-1% -$7.25K 0.05% 233
2025
Q2
$470K Buy
1,682
+299
+22% +$84.7K 0.05% 200
2025
Q1
$431K Buy
1,383
+139
+11% +$41K 0.05% 198
2024
Q4
$324K Buy
1,244
+91
+8% +$27K 0.05% 197
2024
Q3
$372K Buy
1,153
+9
+0.8% +$2.94K 0.06% 159
2024
Q2
$357K Buy
+1,144
New +$336K 0.07% 142

Other funds holding AMGN

Aprio Wealth Management's AMGN Position: Q2 2026 in Review

Aprio Wealth Management reduced its Amgen (AMGN) stake by 0.92% in Q2 2026, selling an estimated $10.6K and leaving 3,328 shares worth $1.21M. The position accounts for 0.06% of the portfolio, ranked #203.

Aprio Wealth Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Aprio Wealth Management held 3,328 shares of Amgen worth $1.21M as of Q2 2026.
  • Aprio Wealth Management sold 31 Amgen shares in Q2 2026, an estimated $10.6K.
  • Amgen made up 0.06% of Aprio Wealth Management's portfolio in Q2 2026, its #203 holding.
  • Aprio Wealth Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.